Physician
Obstetrics & Gynecology
Dr. Edward V. Hannigan, MD
|
|
Give Review
Edward Hannigan works in the field of Obstetrics & Gynecology. He received awards:"Fellow (FACS)". Dr. Edward V. Hannigan is a published doctor and has 78 publications published. The lastest was: 'Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer.'
Publications
- Southwest Oncology Group Trial S9912: intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy ...
- Randomized trial of adjuvant intraperitoneal alpha-interferon in stage III ovarian cancer patients who have no evidence of disease after primary surgery and chemothera...
- Recurrent mature cystic ovarian teratoma in adolescence: atypical case of the growing teratoma syndrome.
- A patient-centered health care delivery system by a university obstetrics and gynecology department.
- Primary gastrointestinal cancers presenting as gynecologic malignancies.
- Frozen cones: they have a niche.
- Combined intraperitoneal and intravenous chemotherapy for women with optimally debulked ovarian cancer: results from an intergroup phase II trial.
- Management of atypical glandular cells of undetermined significance pap smears: a reappraisal.
- Prediction of the need for red cell transfusion in newly diagnosed ovarian cancer patients undergoing platinum-based treatment.
- Using cytology to evaluate the endocervical canal after loop excision.
- Long-term survival with metastatic uterine sarcoma.
- Uterine leiomyosarcoma.
- Carcinoma in situ of the vulva. A clinicopathologic study of 50 cases.
- Frozen section evaluation of cervical conization specimens.
- Treatment of advanced uterine sarcoma with adriamycin.
- Reexploration after treatment for uterine sarcoma.
- Cone biopsy during pregnancy.
- MRI of cervical carcinoma.
- 4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis.
- Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer.
- Cervical cancer in pregnancy.
- XY gonadal dysgenesis with gonadoblastoma and dysgerminoma.
- Three-dimensional endothelial-tumor epithelial cell interactions in human cervical cancers.
- Epithelial ovarian neoplasms of low malignant potential.
- MR imaging of uterine cervical carcinoma.
- Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer.
- Human papillomavirus type 16 found in primary transitional cell carcinoma of the Bartholin's gland and in a lymph node metastasis.
- Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer.
- Flow cytometry in cervical adenocarcinoma. Correlating DNA content analysis with the clinical picture.
- Simultaneously occurring condylomata acuminata, carcinoma in situ and verrucous carcinoma of the vulva and carcinoma in situ of the cervix in a young woman. A case rep...
- Avoiding conization for inadequate colposcopy. Suggestions for conservative therapy.
- Ovarian steroid secretion in postmenopausal women with and without endometrial cancer.
- Necessity for endocervical curettage in elderly women undergoing colposcopy.
- A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers.
- The cytologist and bacterioses of the vaginal-ectocervical area. Clues, commas and confusion.
- Bone metastasis in epithelial ovarian carcinoma.
- Adjuvant chemotherapy in early uterine sarcoma.
- Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide.
- Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix.
- Mixed müllerian tumors of the uterus: a clinicopathologic study.
- Bleomycin, vincristine, and methotrexate with citrovorum factor rescue in the treatment of advanced squamous cell carcinoma of the cervix.
- Mixed mesodermal tumors of the ovary: a clinicopathologic study of 14 cases.
- Management of patients with positive margins after cervical conization.
- m-AMSA and adenocarcinoma of the endometrium. A Southwest Oncology Group study.
- Angiogenin, interleukins, and growth-factor levels in serum of patients with ovarian cancer: correlation with angiogenesis.
- Phase II clinical trial of capecitabine in the treatment of advanced, persistent or recurrent squamous cell carcinoma of the cervix with translational research: a gyne...
- Chronic plasma cell cervicitis simulating a cervical malignancy: a case report.
- Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
- Hyperthecosis of the ovaries in a woman with a placental site trophoblastic tumor.
- Clinical and molecular responses in high-grade intraepithelial neoplasia treated with topical imiquimod 5%.
- Surgical blood loss in abdominal hysterectomy.
- Human papillomavirus testing for triage in a referral population.
- Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
- Outpatient loop electrosurgical excision procedure for cervical intraepithelial neoplasia. Can it replace cold knife conization?
- Tumor board in gynecologic oncology.
- Oncogene expression and microvessel count in recurrent and nonrecurrent stage Ib squamous cell carcinoma of the cervix.
- Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a r...
- Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease.
- Results of a Southwest Oncology Group phase III trial of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide in advanced ovarian cancer.
- Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study.
- Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study.
- Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial...
- Analysis of patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stag...
- Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix.
- Effect of hemodilution on tissue perfusion and blood coagulation during radical hysterectomy.
- Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III ran...
- Evaluation of amonafide in cervical cancer, phase II. A SWOG study.
- Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group...
- Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-...
- Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic ly...
- Implications of tyrosine phosphoproteomics in cervical carcinogenesis.
- Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial.
- Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
- A phase II trial of cisplatin and 5-fluorouracil with allopurinol for recurrent or metastatic carcinoma of the uterine cervix: a Southwest Oncology Group trial.
- A phase II trial of carboplatin for recurrent or metastatic squamous carcinoma of the uterine cervix: a Southwest Oncology Group study.
- Phase II study of fludarabine phosphate (NSC 312887) in patients with advanced cervical cancer. A Southwest Oncology Group study.
- Significance of early changes in the serum CA-125 antigen level on overall survival in advanced ovarian cancer.
Schools
University of Texas At Galveston Medical Branch
University Tex Med Br
US Naval Hospital
MD Anderson Hospital
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- Fellow (FACS)
Helpful Reviews
Similar Doctors
|
|
Dr. Shannon M. Clark, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Marian Y. Williams-Brown, MD |
|
|
Dr. Faranak Behnia, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lyuba Levine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gwyn Richardson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamar Achjian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tochi M. Amagwula, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah C. Rogan, MD |
|
|
Dr. Courtney G. Wiese, MD
This Doctor is OpenDoctor Recommended.
|